What happened
AriBioLab updated the terms of a private placement (third-party allotment) to raise US$1.95M, about 2.8% of its market value.
For context, this raise equals about 2.8% of the company's market value, which is the rough scale of potential new-share dilution.
| Instrument | Private placement |
|---|---|
| Raise amount | US$1.95M |
| vs. market value | 2.8% |
| Filed | 2026-06-22, [Amended] Material event report (rights offering) |
| Source | DART rcept 20260622000241 → open original filing |
Source: DART. Information only, not investment advice.